| abstract |
Provided is a method for promoting and inhibiting hematopoietic stem cell proliferation in a subject comprising administering a hematopoietic stem cell modulator and a pharmaceutically acceptable carrier. The substance promoting the proliferation of hematopoietic stem cells is prostaglandin (PG) E2, PGI2, linoleic acid, meade acid, eicosatrienoic acid, epoxyeicosatrienoic acid, forskolin, phendiline, nicardipine, nifedipine, The group consisting of pimozide, strophantidine, ranatoside, L-arginine, sodium nitroprusside, sodium vanadate, bradykinin, atenolol, pindolol, hydralazine, etc., and substances that inhibit the proliferation of hematopoietic stem cells are indomethacin, fenbufen, sulindac, sikisibzone A method for promoting and inhibiting hematopoietic stem cell proliferation, selected from the group consisting of aspirin, naproxen, ibuprofen, celecoxib, PGJ2, aristolochic acid and the like. 【Selection chart】 None |